These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36100278)

  • 1. In Vitro Comparison of Two Blister-Type Inhalers.
    Kondo T; Tanigaki T; Hibino M; Tajiri S; Horiuchi S; Maeda K; Tobe S
    Respir Care; 2023 Mar; 68(3):338-345. PubMed ID: 36100278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total emitted dose of salbutamol sulphate at different inhalation flows and inhalation volumes through different types of dry powder inhalers.
    Boshra MS; Almeldien AG; Salah Eldin R; Elberry AA; Abdelwahab NS; Nabil Salem M; Rabea H; Abdelrahim MEA
    Exp Lung Res; 2018; 44(4-5):211-216. PubMed ID: 30346848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ELLIPTA® Dry Powder Inhaler: Design, Functionality, In Vitro Dosing Performance and Critical Task Compliance by Patients and Caregivers.
    Grant AC; Walker R; Hamilton M; Garrill K
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):474-85. PubMed ID: 26372466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Preference Study of Two Placebo Dry Powder Inhalers in Adults with COPD: ELLIPTA® Dry Powder Inhaler (DPI) versus DISKUS® DPI.
    Yun Kirby S; Zhu CQ; Kerwin EM; Stanford RH; Georges G
    COPD; 2016; 13(2):167-75. PubMed ID: 26516724
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Hamilton M; Anderson M; Dhand R; Patmore O; Prime D; Taylor E
    J Aerosol Med Pulm Drug Deliv; 2023 Feb; 36(1):34-43. PubMed ID: 36695722
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of peak inspiratory flow rate via the Breezhaler®, Ellipta® and HandiHaler® dry powder inhalers in patients with moderate to very severe COPD: a randomized cross-over trial.
    Altman P; Wehbe L; Dederichs J; Guerin T; Ament B; Moronta MC; Pino AV; Goyal P
    BMC Pulm Med; 2018 Jun; 18(1):100. PubMed ID: 29898702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical Error Frequency and the Impact of Training with Inhalers Commonly used for Maintenance Treatment in Chronic Obstructive Pulmonary Disease.
    Collier DJ; Wielders P; van der Palen J; Heyes L; Midwinter D; Collison K; Preece A; Barnes N; Sharma R
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1301-1313. PubMed ID: 32606640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, open-label, single-visit, crossover study simulating triple-drug delivery with Ellipta compared with dual inhaler combinations in patients with COPD.
    van der Palen J; Moeskops-van Beurden W; Dawson CM; James WY; Preece A; Midwinter D; Barnes N; Sharma R
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2515-2523. PubMed ID: 30174421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and factors associated with suboptimal peak inspiratory flow rates in COPD.
    Ghosh S; Pleasants RA; Ohar JA; Donohue JF; Drummond MB
    Int J Chron Obstruct Pulmon Dis; 2019; 14():585-595. PubMed ID: 30880948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chinese expert consensus on standardized inhaler device application in stable chronic airway diseases (2023)].
    Inhalation Therapy and Respiratory Rehabilitation Group, Respiratory Equipment Committee of China Association of Medical Equipment
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Nov; 46(11):1055-1067. PubMed ID: 37914418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA® Dry Powder Inhaler.
    Prime D; de Backer W; Hamilton M; Cahn A; Preece A; Kelleher D; Baines A; Moore A; Brealey N; Moynihan J
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):486-97. PubMed ID: 26372467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised open-label cross-over study of inhaler errors, preference and time to achieve correct inhaler use in patients with COPD or asthma: comparison of ELLIPTA with other inhaler devices.
    van der Palen J; Thomas M; Chrystyn H; Sharma RK; van der Valk PD; Goosens M; Wilkinson T; Stonham C; Chauhan AJ; Imber V; Zhu CQ; Svedsater H; Barnes NC
    NPJ Prim Care Respir Med; 2016 Nov; 26():16079. PubMed ID: 27883002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of dry powder inhalers with a focus on ease of use and user preference in inhaler-naïve individuals.
    von Schantz S; Katajavuori N; Antikainen O; Juppo A
    Int J Pharm; 2016 Jul; 509(1-2):50-58. PubMed ID: 27208655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled salbutamol from aerolizer and diskus at different inhalation flows, inhalation volume and number of inhalations in both healthy subjects and COPD patients.
    Boshra MS; Almeldien AG; Eldin RS; Elberry AA; Abdelwahab NS; Salem MN; Rabea H; Abdelrahim MEA
    Exp Lung Res; 2019; 45(3-4):84-91. PubMed ID: 31155973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exhalation immediately before inhalation optimizes dry powder inhaler use.
    Kondo T; Hibino M; Tanigaki T; Ohe M; Kato S
    J Asthma; 2015; 52(9):935-9. PubMed ID: 26513654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Qualitative assessment of attributes and ease of use of the ELLIPTA™ dry powder inhaler for delivery of maintenance therapy for asthma and COPD.
    Svedsater H; Dale P; Garrill K; Walker R; Woepse MW
    BMC Pulm Med; 2013 Dec; 13():72. PubMed ID: 24314123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-time handling of different inhalers by chronic obstructive lung disease patients.
    Harb HS; Laz NI; Rabea H; Abdelrahim MEA
    Exp Lung Res; 2020 Sep; 46(7):258-269. PubMed ID: 32614625
    [No Abstract]   [Full Text] [Related]  

  • 18. The Ellipta
    Jones TL; Neville DM; Chauhan AJ
    Ther Deliv; 2018 Feb; 9(3):169-176. PubMed ID: 29424288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the Small Airways with Inhaled Corticosteroid/Long-Acting Beta Agonist Dry Powder Inhalers: A Functional Respiratory Imaging Study.
    Watz H; Barile S; Guastalla D; Topole E; Cocconi D; Mignot B; Belmans D; Duman D; Poli G; Fabbri LM
    J Aerosol Med Pulm Drug Deliv; 2021 Sep; 34(5):280-292. PubMed ID: 33944614
    [No Abstract]   [Full Text] [Related]  

  • 20. [A STUDY OF INSPIRATORY RESISTANCE OF DRY POWDER INHALER OF AGENTS FOR ASTHMA CONTROL].
    Suda S; Konno R; Kurosawa H; Tamura G
    Arerugi; 2016 Jul; 65(7):932-6. PubMed ID: 27545059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.